Pictet Asset Management Portfolio holdings
AUM
$98.3B
1-Year Return
21%
This Quarter Return
+14.1%
1 Year Return
+21%
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$98.3B
AUM Growth
+$8.28B
(+9.2%)
Cap. Flow
-$1.44B
Cap. Flow
% of AUM
-1.46%
Top 10 Holdings %
Top 10 Hldgs %
19.88%
Holding
2,078
New
69
Increased
731
Reduced
969
Closed
78
Top Buys
| 1 |
AMRZ
Amrize Ltd
AMRZ
|
$251M |
| 2 |
Alphabet (Google) Class A
GOOGL
|
$238M |
| 3 |
NVIDIA
NVDA
|
$206M |
| 4 |
Dominion Energy
D
|
$193M |
| 5 |
Spotify
SPOT
|
$162M |
Top Sells
| 1 |
KLA
KLAC
|
$213M |
| 2 |
Zscaler
ZS
|
$188M |
| 3 |
Republic Services
RSG
|
$185M |
| 4 |
ANSS
Ansys
ANSS
|
$185M |
| 5 |
Informatica
INFA
|
$182M |
Sector Composition
| 1 | Technology | 34.74% |
| 2 | Industrials | 16.05% |
| 3 | Healthcare | 11.57% |
| 4 | Financials | 8.09% |
| 5 | Consumer Discretionary | 7.42% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
326
Bank of New York Mellon
BK
$73.5B
| $46.3M | 0.05% |
508,411
+12,542
| +3% | +$1.14M |
|
327
Xenon Pharmaceuticals
XENE
$2.96B
| $46.2M | 0.05% |
1,474,449
-3,168
| -0.2% | -$99.2K |
|
328
West Pharmaceutical
WST
$18.2B
| $46.1M | 0.05% |
210,502
+76,151
| +57% | +$16.7M |
|
329
Duke Energy
DUK
$93.7B
| $46M | 0.05% |
389,923
+32,405
| +9% | +$3.82M |
|
330
Truist Financial
TFC
$59.2B
| $45.9M | 0.05% |
1,068,840
+220,631
| +26% | +$9.48M |
|
331
PNC Financial Services
PNC
$79.7B
| $45.8M | 0.05% |
245,834
+1,528
| +0.6% | +$285K |
|
332
Oneok
OKE
$45B
| $45.8M | 0.05% |
561,059
+91,936
| +20% | +$7.5M |
|
333
Altria Group
MO
$111B
| $45.7M | 0.05% |
779,860
+3,280
| +0.4% | +$192K |
|
334
Summit Therapeutics
SMMT
$14.8B
| $45.6M | 0.05% |
2,163,873
-497,731
| -19% | -$10.5M |
|
335
Paychex
PAYX
$48.7B
| $45.4M | 0.05% |
311,934
+31,437
| +11% | +$4.57M |
|
336
Nuvalent
NUVL
$5.84B
| $45M | 0.05% |
589,832
+35,691
| +6% | +$2.72M |
|
337
Ventas
VTR
$30.9B
| $44.7M | 0.05% |
708,268
-62,482
| -8% | -$3.95M |
|
338
Bank of Montreal
BMO
$90.6B
| $44.5M | 0.05% |
402,737
+3,879
| +1% | +$429K |
|
339
Travelers Companies
TRV
$61.8B
| $43.6M | 0.04% |
162,820
-4,610
| -3% | -$1.23M |
|
340
Thomson Reuters
TRI
$78B
| $43.5M | 0.04% |
216,770
-153
| -0.1% | -$30.7K |
|
341
iShares Core S&P 500 ETF
IVV
$666B
| $43.3M | 0.04% |
70,100
+14,300
| +26% | +$8.83M |
|
342
Enbridge
ENB
$105B
| $43.3M | 0.04% |
955,814
+18,751
| +2% | +$849K |
|
343
United Parcel Service
UPS
$71.2B
| $43.2M | 0.04% |
428,237
+13,492
| +3% | +$1.36M |
|
344
Axsome Therapeutics
AXSM
$6.32B
| $43M | 0.04% |
411,850
+78,645
| +24% | +$8.21M |
|
345
Colgate-Palmolive
CL
$68.1B
| $43M | 0.04% |
472,659
+5,873
| +1% | +$534K |
|
346
Protagonist Therapeutics
PTGX
$3.51B
| $41.6M | 0.04% |
751,977
+456,384
| +154% | +$25.2M |
|
347
Darling Ingredients
DAR
$4.92B
| $41.4M | 0.04% |
1,089,925
-89,550
| -8% | -$3.4M |
|
348
Strategy Inc Common Stock Class A
MSTR
$93.8B
| $41.2M | 0.04% |
101,945
+18,568
| +22% | +$7.5M |
|
349
TransDigm Group
TDG
$71.4B
| $40.7M | 0.04% |
26,792
+318
| +1% | +$484K |
|
350
Arthur J. Gallagher & Co
AJG
$76.2B
| $40M | 0.04% |
125,099
+11,199
| +10% | +$3.58M |
|